Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
3R01NS029769-01A1S1
Application #
3416656
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1992-04-01
Project End
1995-03-31
Budget Start
1992-06-15
Budget End
1993-03-31
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Windebank, A J (1999) Chemotherapeutic neuropathy. Curr Opin Neurol 12:565-71
Gill, J S; Schenone, A E; Podratz, J L et al. (1998) Autocrine regulation of neurite outgrowth from PC12 cells by nerve growth factor. Brain Res Mol Brain Res 57:123-31
Schenone, A; Gill, J S; Zacharias, D A et al. (1996) Expression of high- and low-affinity neurotrophin receptors on human transformed B lymphocytes. J Neuroimmunol 64:141-9
Sun, X; Windebank, A J (1996) Calcium in suramin-induced rat sensory neuron toxicity in vitro. Brain Res 742:149-56
Gill, J S; Connolly, D C; McManus, M J et al. (1996) Suramin induces phosphorylation of the high-affinity nerve growth factor receptor in PC12 cells and dorsal root ganglion neurons. J Neurochem 66:963-72
Gill, J S; Hobday, K L; Windebank, A J (1995) Mechanism of suramin toxicity in stable myelinating dorsal root ganglion cultures. Exp Neurol 133:113-24
Russell, J W; Windebank, A J; Podratz, J L (1994) Role of nerve growth factor in suramin neurotoxicity studied in vitro. Ann Neurol 36:221-8